FDA MedWatch - GE Healthcare, LLC, Giraffe and Panda T-Piece Resuscitation Systems and Mask Resuscitation Systems: Class 1 Recall - Potential Reversal of Oxygen/Air

[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]

 



Title: FDA MedWatch - GE Healthcare, LLC, Giraffe and Panda T-Piece Resuscitation Systems and Mask Resuscitation Systems: Class 1 Recall - Potential Reversal of Oxygen/Air
MedWatch logoMedWatch - The FDA Safety Information and Adverse Event Reporting Program

GE Healthcare, LLC, Giraffe and Panda T-Piece Resuscitation Systems and Mask Resuscitation Systems: Class 1 Recall - Potential Reversal of Oxygen/Air

AUDIENCE: Risk Managers, Pulmonology

ISSUE: The oxygen and air wall inlet fittings and/or labels on the back panel of the resuscitation systems may have been reversed during assembly. As a result, this could potentially reverse the air/oxygen concentrations; for example, a setting of 100% oxygen could have an output of 21% oxygen and vice versa. The settings of the blender knob would no longer be accurate.

This product may cause serious adverse health consequences, including death.

BACKGROUND:  The Giraffe and Panda T-Piece Resuscitation Systems and the Giraffe Panda Bag and Mask Resuscitation Systems provide the basic equipment required for pulmonary resuscitation of infants. On October 15, 2012, GE Healthcare sent its affected customers an "Urgent Medical Device Correction" letter with a return receipt. The letter identified the product, the problem, and the action to be taken by the customer along with the product correction.

RECOMMENDATION:

Healthcare professionals and patients are encouraged to report adverse events or side effects related to the use of these products to the FDA's MedWatch Safety Information and Adverse Event Reporting Program:

Read the complete MedWatch Safety Alert, including a link to the Recall Notice, at:

http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm339884.htm


This email was sent to list-fda@xxxxxxxxxxx using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420 Powered by GovDelivery

[Index of Archives]     [CDC News]     [NIH News]     [USDA News]     [Steve's Art]     [Camping in Yosemite]     [PhotoForum]     [SB Lupus]     [STB]

  Powered by Linux